| Aug 2, 2026 | Excellus BlueCross BlueShield | Light and Laser Therapies for Dermatologic ConditionsPayerPolicy · EXCELLUS-8-01-21 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Level of Care Criteria for Inpatient, Residential, Partial Hospital, and Intensive Outpatient Mental Health Services for Adults and ChildrenPayerPolicy · EXCELLUS-3-01-21 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Left Atrial Appendage Closure DevicesPayerPolicy · EXCELLUS-7-01-92 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Laboratory Testing for Transplantation RejectionPayerPolicy · EXCELLUS-2-02-55 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Laboratory Testing for the Screening and Management of Prostate CancerPayerPolicy · EXCELLUS-2-02-48 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Lab Testing for Alzheimer’s DiseasePayerPolicy · EXCELLUS-2-02-16 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Kidney TransplantationPayerPolicy · EXCELLUS-7-02-04 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Ketamine Infusion Therapy for the Treatment of Chronic Pain SyndromesPayerPolicy · EXCELLUS-7-03-03-BC51305F76 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Ketamine for the Treatment of Psychiatric DisordersPayerPolicy · EXCELLUS-3-01-13-E93C0AA928 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | JAK2, MPL, and CALR Testing for Myeloproliferative NeoplasmsPayerPolicy · EXCELLUS-2-02-53 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Intraocular Lens (IOL) ImplantsPayerPolicy · EXCELLUS-9-01-14 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Intradiscal ProceduresPayerPolicy · EXCELLUS-7-01-112 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Intradiscal Procedures (Effective 2026-10-15)PayerPolicy · EXCELLUS-7-01-112-FUTURE | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Interfacility Transfer of a Registered InpatientPayerPolicy · EXCELLUS-11-01-18 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Injectable Fillers for Dermal and Laryngeal ConditionsPayerPolicy · EXCELLUS-7-01-119 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Inflammatory Markers of Coronary Artery Disease RiskPayerPolicy · EXCELLUS-2-02-15 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Implantable Cardioverter Defibrillator (ICD)PayerPolicy · EXCELLUS-7-01-06 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Implantable Bone Conduction Hearing AidsPayerPolicy · EXCELLUS-7-01-77 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Implantable and Invasive Neuromodulation SystemsPayerPolicy · EXCELLUS-1-01-60 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | ImmunizationsPayerPolicy · EXCELLUS-2-01-42-47C4ACB6B0 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Hyperbaric Oxygen Therapy (HBOT)PayerPolicy · EXCELLUS-2-01-07 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Home Non-Invasive Positive Pressure Ventilation (NIPPV) Devices for Respiratory Insufficiency and Failure (Effective 2026-10-15)PayerPolicy · EXCELLUS-1-01-57 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Home Birth by Certified Nurse MidwivesPayerPolicy · EXCELLUS-11-01-23 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Home Automatic External Defibrillators (AEDs) and Wearable Cardioverter Defibrillators (WCDs)PayerPolicy · EXCELLUS-1-01-42 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Hip ArthroplastyPayerPolicy · EXCELLUS-7-01-96 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Hip Arthroplasty (Effective 2026-10-15)PayerPolicy · EXCELLUS-7-01-96-FUTURE | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Heart Failure Management DevicesPayerPolicy · EXCELLUS-7-01-91 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Heart & Heart/Lung TransplantPayerPolicy · EXCELLUS-7-02-06 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Germline Genetic Testing for Hereditary CancersPayerPolicy · EXCELLUS-2-02-60 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Genetic Testing for Thoracic Aortic Aneurysms/ Dissections and Connective Tissue Related DisordersPayerPolicy · EXCELLUS-2-02-61-43C88B0FD2 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Genetic Testing for Inherited DisordersPayerPolicy · EXCELLUS-2-02-03 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Genetic Testing for Cystic FibrosisPayerPolicy · EXCELLUS-2-02-17 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Genetic Testing for Cardiac Ion ChannelopathiesPayerPolicy · EXCELLUS-2-02-38 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Genetic Assay of Tumor Tissue to Determine Prognosis and Treatment of Breast CancerPayerPolicy · EXCELLUS-2-02-27 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Gene Expression Profiling for Cutaneous MelanomaPayerPolicy · EXCELLUS-2-02-52 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Gender Reassignment/Gender Affirming Surgery and Treatments for Medicaid Managed Care Plan (MMCP) and Health and Recovery Plan (HARP) MembersPayerPolicy · EXCELLUS-7-01-105 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Gender Affirming Surgery and Treatments for Commercial and Medicare Advantage MembersPayerPolicy · EXCELLUS-7-01-84 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Gender Affirming Behavioral Health and Medical ServicesPayerPolicy · EXCELLUS-3-01-22 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Gastric Electrical StimulationPayerPolicy · EXCELLUS-7-01-64 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Foot OrthoticsPayerPolicy · EXCELLUS-1-01-41 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Focal Therapies for Prostate Cancer TreatmentPayerPolicy · EXCELLUS-7-01-01 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Fecal Microbiota TransplantationPayerPolicy · EXCELLUS-2-01-48 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Facet Joint Injections/ Medial Branch BlocksPayerPolicy · EXCELLUS-7-01-116 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Facet Joint Injections/ Medial Branch Blocks (Effective 2026-10-15)PayerPolicy · EXCELLUS-7-01-116-FUTURE | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Extracorporeal Shock Wave Therapy (ESWT) for Muscoloskeletal Conditions and Soft Tissue WoundsPayerPolicy · EXCELLUS-2-01-31 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Extracorporeal Photochemotherapy/PhotopheresisPayerPolicy · EXCELLUS-8-01-01 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | External Prosthetic Devices (Effective 2026-08-17)PayerPolicy · EXCELLUS-1-01-18-823D5012C8 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | External Prosthetic DevicesPayerPolicy · EXCELLUS-1-01-18-29ACB17D0B | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Experimental or Investigational ServicesPayerPolicy · EXCELLUS-11-01-03 | New policy |
|---|
| Aug 2, 2026 | Excellus BlueCross BlueShield | Evoked PotentialsPayerPolicy · EXCELLUS-2-01-27 | New policy |
|---|